Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dexamethasone for Symptomatic Irreversible Pulpitis
NCT05761730Phase 1Unknown
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexamethasone in irreversible pulpitis (2 arms). Primary endpoint: Pain intensity on Visual Analog Scale at 24 hours. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT05761730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05761730.